Search form

Prostate health

Since 2006, Hologic has been instrumental in advancing the detection of prostate cancer, helping physicians resolve one of the most puzzling diagnostic problems: deciding which patients - who have previously had one or more negative prostate biopsies - require an additional biopsy. There is no single objective practice or widely used standard guideline for performing  repeat biopsies  following an initial negative biopsy and continued suspicion of prostate cancer.  Since prostate biopsies can miss malignancies, many unnecessary repeat biopsies are conducted in a conservative effort to avoid missing a cancer diagnosis. Hologic’s quest to resolve this critical issue and protect men's health fuels our continued development of superior prostate cancer testing solutions.